Cytovation

Private

BergenHealthcare & Life Scienceshttps://www.cytovation.com/

Last Round

Series A

Extension

Apr 23, 2025

Total Funding Raised

$34M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Cytovation ASA is a clinical-stage biotech company that develops treatments for solid tumors in oncology and rare diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

immuno-oncologypeptide therapeuticssolid tumor treatmentclinical-stage biotechcancer immunotherapyWnt/β-catenin pathwayintratumoral injectionadrenocortical carcinomaACCcombination therapyOrphan Drug Designationrare disease treatmenthead and neck squamous cell carcinomaHNSCCtriple-negative breast cancerTNBCHPV-induced warts

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cytovation Comps

Public and private peers based on sector, stage, and business model.

Cytovation comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Cytovation Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A Extension	Apr 23, 2025
Series A Extension	Jun 2, 2023
Series A	Jan 25, 2022
Private Placement	Jan 8, 2018
Private Placement	Jun 29, 2017

View all Funding Rounds

Key People

Founding team and executive leadership

Lars Prestegarden

Chief Executive Officer

Executive Team

Federico Grego

COO & CFO

Executive Team

Vetle Gullaksen Veiteberg

Deputy CFO

Executive Team

Cytovation Investors

Notable investors and investment history

Cytovation investors
Investor	Rounds
Canica	Series A Extension, Series A
Sandwater	Series A Extension, Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Apr 19, 2026
Monthly visitors grew 669% MoM, reaching 3.2K.
Apr 23, 2025
$6M round led by Sandwater.

View all signals

Cytovation Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Cytovation Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cytovation's valuation, stock price, and market status.

Firmographic Details

HeadquartersBergen

Employee Range13

Year Founded2001

Last FundingApr 23, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.